Skip to Content

Danaher Corp DHR

Morningstar Rating
$261.25 −3.42 (1.29%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Danaher Aims to Rebound in 2024 After Tough 2023 Reset Period

Through its Danaher Business System, Danaher aims for continuous improvement of its scientific technology portfolio by seeking out attractive markets and then making acquisitions to enter or expand within those fields and also divesting assets that are no longer seen as core, such as the recently divested Veralto operations. After acquisitions, Danaher aims to accelerate core growth at acquired companies by making research and development and marketing-related investments. It also implements lean manufacturing principles and administrative cost controls to boost operating margins. Overall, we appreciate Danaher's strategic moves, which have pushed it into attractive end markets with strong growth prospects and sticky, recurring revenue streams.

Price vs Fair Value

DHR is trading at a 812% premium.
Price
$264.67
Fair Value
$517.00
Uncertainty
Medium
1-Star Price
$371.84
5-Star Price
$443.80
Economic Moat
Yrkjw
Capital Allocation
Vcdkytscl

Bulls Say, Bears Say

Bulls

The Danaher Business System focuses on continuous improvement, including the acceleration of core growth and margin expansion through marketing initiatives and innovation, which appears positive for Danaher's long-term prospects.

Bears

Danaher continues to hunt for acquisitions in the life sciences and diagnostics markets, which could constrain ROICs including goodwill if it makes acquisitions at unattractive prices and is not able to integrate them as successfully as in the past.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if DHR is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$264.67
Day Range
$260.29264.58
52-Week Range
$182.09269.11
Bid/Ask
$260.57 / $262.14
Market Cap
$193.50 Bil
Volume/Avg
3.4 Mil / 2.7 Mil

Key Statistics

Price/Earnings (Normalized)
32.56
Price/Sales
8.71
Dividend Yield (Trailing)
0.40%
Dividend Yield (Forward)
0.41%
Total Yield
0.40%

Company Profile

In 1984, Danaher’s founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divesititure of its environmental and applied solutions group, Veralto.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Large Core
Total Number of Employees
63,000

Competitors

Valuation

Metric
DHR
TMO
MRK
Price/Earnings (Normalized)
32.5626.9023.20
Price/Book Value
3.654.882.66
Price/Sales
8.715.303.57
Price/Cash Flow
29.6725.9417.07
Price/Earnings
DHR
TMO
MRK

Financial Strength

Metric
DHR
TMO
MRK
Quick Ratio
1.341.190.72
Current Ratio
1.851.701.29
Interest Coverage
15.854.8310.23
Quick Ratio
DHR
TMO
MRK

Profitability

Metric
DHR
TMO
MRK
Return on Assets (Normalized)
5.15%8.69%5.60%
Return on Equity (Normalized)
8.40%18.71%10.13%
Return on Invested Capital (Normalized)
6.02%10.97%7.63%
Return on Assets
DHR
TMO
MRK
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Thermo Fisher Scientific Inc
TMO
HbfxhknyzJrpt$221.8 Bil
IDEXX Laboratories Inc
IDXX
TtgyqxwrsgBtfjwj$42.0 Bil
IQVIA Holdings Inc
IQV
FkblqtqhgLlssm$39.3 Bil
Agilent Technologies Inc
A
VtnhgclcyDvgyd$38.8 Bil
Mettler-Toledo International Inc
MTD
ZwlclrrmshMfkcmc$30.8 Bil
Icon PLC
ICLR
KggsbhhqFzxxvhj$26.5 Bil
Waters Corp
WAT
WjhzbdzqXsf$17.9 Bil
Illumina Inc
ILMN
BtyyqjjqlLwrqx$17.5 Bil
Labcorp Holdings Inc
LH
KrtxjqtchWgksvqf$16.5 Bil

Sponsor Center